BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cipla
Fuji
AstraZeneca
Argus Health
Moodys
Citi
Baxter
McKinsey
Federal Trade Commission
Covington

Generated: January 18, 2018

DrugPatentWatch Database Preview

Trifluoperazine hydrochloride - Generic Drug Details

« Back to Dashboard

What are the generic sources for trifluoperazine hydrochloride and what is the scope of trifluoperazine hydrochloride patent protection?

Trifluoperazine hydrochloride
is the generic ingredient in two branded drugs marketed by Glaxosmithkline, Sandoz, Wockhardt, Duramed Pharms Barr, Ivax Pharms, Mylan, and Watson Labs, and is included in twenty-one NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for trifluoperazine hydrochloride. Eight suppliers are listed for this compound.
Pharmacology for trifluoperazine hydrochloride
Ingredient-typePhenothiazines
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for trifluoperazine hydrochloride

US Patents and Regulatory Information for trifluoperazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sandoz TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040153-004 Oct 25, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 085786-001 Approved Prior to Jan 1, 1982 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Sandoz TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040153-003 Oct 25, 1996 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 087612-001 Nov 19, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040209-003 Jul 7, 1997 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Ivax Pharms TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 087613-001 Nov 19, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Wockhardt TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride CONCENTRATE;ORAL 088143-001 Jul 26, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040209-002 Jul 7, 1997 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040209-004 Jul 7, 1997 AB RX No Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mylan TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040209-001 Jul 7, 1997 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Merck
Dow
Covington
Accenture
US Army
Baxter
Fuji
Farmers Insurance
Novartis

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot